Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

An experimental device for removing blood clots in stroke patients dramatically outperformed the standard mechanical treatment, according to research presented by UCLA Stroke Center director Dr. Jeffrey L. Saver at the American Stroke Association’s 2012 international conference in New Orleans…

 

A research team led by investigators at Mayo Clinic in Florida has found that a small device worn on a patient’s brow can be useful in monitoring stroke patients in the hospital. The device measures blood oxygen, similar to a pulse oximeter, which is clipped onto a finger…

 

An irregular heartbeat that you don’t even feel but can be picked up by a pacemaker is associated with a significantly increased risk of stroke, says a new McMaster University study…

 

Collaborative stroke research study in January 2012 Archives of Physical Medicine & Rehabilitation shows bedside clinical evaluation can detect spatial neglect, a common disabling cognitive disorder that impedes recovery for 30 to 50% of stroke survivors. West Orange, NJ. January 3, 2012…

 

Severely impaired stroke survivors could walk better when a robotic assist system was added to conventional rehabilitation, according to a study in Stroke: Journal of the American Heart Association. Italian researchers evaluated two-year mobility outcomes in 48 stroke survivors who had been discharged from a hospital and were unable to walk at the study’s start…

 

A simple function that most of us take for granted - swallowing - is the focus of University of Adelaide research which could help thousands of stroke sufferers around the world…

 

Today, Penumbra, Inc. announced the Shonin approval by the Japanese Ministry of Health, Labor and Welfare of the Penumbra System for revascularization of patients with acute ischemic stroke. Penumbra, together with its exclusive distribution partner, Medico’s Hirata, Inc., will begin immediate commercialization of the device in Japan…

 

Bioness Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its NESS L300® Plus System. The device combines the Company’s NESS L300® Foot Drop System with a thigh stimulation cuff, to provide knee flexion and extension in addition to ankle dorsiflexion during gait…

 

Bioness Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its NESS L300® Plus System. The device combines the Company’s NESS L300® Foot Drop System with a thigh stimulation cuff, to provide knee flexion and extension in addition to ankle dorsiflexion during gait…

 

New research from the University of Calgary’s Faculty of Medicine shows that doctors can make a stroke diagnosis using an iPhone application with the same accuracy as a diagnosis at a medical computer workstation. This technology can be particularly useful in rural medical settings…




May 2012
Mon Tue Wed Thu Fri Sat Sun
« Apr    
 123456
78910111213
14151617181920
21222324252627
28293031